Patents Assigned to The Cleveland Clinic Foundation
-
Patent number: 11246844Abstract: A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO by providing a composition comprising a compound set forth in Formula (I):Type: GrantFiled: May 31, 2017Date of Patent: February 15, 2022Assignees: The Procter & Gamble Company, The Cleveland Clinic FoundationInventors: Stanley Leon Hazen, Jose Carlos Garcia-Garcia, George Franklin Gerberick, John August Wos, Xiaodong Gu, Michael Reilly, Mark Robert Sivik, Jodie Michelle Reed, David Blair Cody
-
Patent number: 11241313Abstract: An apparatus for partially supporting a leaflet of a regurgitant heart valve comprises at least one subvalvular device including a subvalvular supporting portion including a leaflet-contacting upper supporter surface longitudinally spaced from an oppositely facing lower supporter surface. A supporter perimeter wall extends longitudinally between the upper and lower supporter surfaces, with at least a portion contacting a subvalvular cardiac wall adjacent to the heart valve. An anchor portion is adjacent to, and longitudinally spaced from, the upper supporter surface. The anchor portion includes a leaflet-contacting lower anchor surface longitudinally spaced from an oppositely facing upper anchor surface. A connector neck is interposed longitudinally between, and is directly attached to both of, the upper supporter surface and the lower anchor surface. The connector neck penetrates longitudinally through at least one of a base of the leaflet and an annulus of the heart valve at a manufactured puncture site.Type: GrantFiled: December 12, 2019Date of Patent: February 8, 2022Assignee: THE CLEVELAND CLINIC FOUNDATIONInventors: Jose L. Navia, Samir Kapadia, Marwane Berrada
-
Patent number: 11241189Abstract: A sensing device can be placed within the colon to study bowel function. The sensing device can include a flexible printed circuit board that includes at least one senor configured to record data related to bowel activity from a patient's colon; and a wireless transmitter configured to send the data from the patient's colon to an external device. The sensing device can also include at least one mucosal clip configured to fix the sensor board to a wall of the patient's colon for a measurement period. The flexible printed circuit board and/or the at least one mucosal clip are configured to be passed from the patient's colon after the measurement period through normal defecation.Type: GrantFiled: July 17, 2019Date of Patent: February 8, 2022Assignees: THE CLEVELAND CLINIC FOUNDATION, THE METROHEALTH SYSTEM, THE U.S. GOV'T AS REPRESENTED BY THE DEPT OF VETERANS AFFAIRSInventors: Aref Smiley, Dennis Bourbeau, Margot S. Damaser, Steve Majerus, Massarat Zutshi, Ian Mcadams
-
Patent number: 11235028Abstract: The use and screening of modulators of apoptosis is disclosed. The modulators may be, for example, modulator of NF-?B activity. The modulators may be used, for example, in the treatment of NF-?B-mediated diseases, conditions, and injuries.Type: GrantFiled: July 31, 2019Date of Patent: February 1, 2022Assignee: The Cleveland Clinic FoundationInventor: Andrei V. Gudkov
-
Patent number: 11229537Abstract: An introduction arrangement for a fenestrated or branched stent graft intended for deployment into the lumen of a vessel having a blind vessel extending from it. The introducer has a distal end intended to remain outside a patient in use and a proximal end with a nose cone dilator and an arrangement to retain the branched stent graft distally of the nose cone dilator. A sheath on the introducer extends over the branched stent graft to the nose cone dilator. An indwelling catheter extends from the distal end of the introducer and enters the fenestration or side arm and through to the nose cone dilator, the indwelling catheter has a guide wire extending through it. The guide wire can be extended beyond the nose cone dilator in use before the sheath is withdrawn from the branched stent graft so that it can be snared from the contra-lateral artery.Type: GrantFiled: January 24, 2019Date of Patent: January 25, 2022Assignees: The Cleveland Clinic Foundation, Cook Medical Technologies LLCInventors: David Ernest Hartley, John Lennon Anderson, Roy K. Greenberg, Wolf Stelter
-
Patent number: 11213305Abstract: A guide for placing a landmark(s) in a patient tissue comprises a central portion defining at least one guiding bore configured to receive and guide a tool for placing the at least one landmark in the patient tissue. Extended portions project away from the central portion, each of the extended portions having respective lower base surfaces contoured to mate with the patient tissue, at least the respective lower base surfaces being customized as a function of preoperative imaging of the patient tissue, whereby the guide is specific to the patient.Type: GrantFiled: November 5, 2018Date of Patent: January 4, 2022Assignee: THE CLEVELAND CLINIC FOUNDATIONInventors: Joseph P. Iannotti, Wael K. Barsoum, Jason A. Bryan, Peter D. O'Neill
-
Patent number: 11211167Abstract: Heterogeneity for biomarkers in a tissue sample can be calculated. A heterogeneity score can be combined with an immunohistochemistry combination score to provide breast cancer recurrence prognosis. Heterogeneity can be based on percent positivity determinations for a plurality of biomarkers according to how many cells in the sample stain positive. An immunohistochemistry combination score can be calculated. An imaging tool can support a digital pathologist workflow that includes designating fields of view in an image of the tissue sample. Based on the fields of view, a heterogeneity metric can be calculated and combined with an immunohistochemistry combination score to generate a breast cancer recurrence prognosis score.Type: GrantFiled: December 19, 2013Date of Patent: December 28, 2021Assignees: VENTANA MEDICAL SYSTEMS, INC., THE CLEVELAND CLINIC FOUNDATION, THE UNIVERSITY OF MELBOURNEInventors: Srinivas Chukka, Olcay Sertel, Anindya Sarkar, Nikolaus Wick, Shalini Singh, Crystal Schemp, Paul Waring, Raymond Tubbs
-
Patent number: 11207013Abstract: The present disclosure relates generally to estimating an interior diameter of a hollow organ. As such, one aspect of the present disclosure relates to a system that can include a light-based distance sensor and a device housing the light-based distance sensor located within the hollow organ. The light-based distance sensor can include an emitter and a detector. The emitter can transmit a conical beam of light to an inner surface of a hollow organ. The detector can receive a portion of the light back-reflected from the inner surface of the hollow organ. The device can determine a volume of the hollow organ based on a signal related to the back-reflected portion of the light, which can be based on a distance between the light-based distance sensor and the inner surface of the hollow organ.Type: GrantFiled: January 26, 2017Date of Patent: December 28, 2021Assignees: THE CLEVELAND CLINIC FOUNDATION, THE DEPARTMENT OF VETERANS AFFAIRSInventors: Margot S. Damaser, Steve Majerus
-
Patent number: 11191886Abstract: A device for minimizing obstruction in a medical device that carries fluids includes a housing defining a channel configured to receive and secure a section of the medical device such that the section of the medical device extends coaxially with a central longitudinal axis of the channel. The device also includes components supported in the housing, including a motor, wherein the components are configured to be operated to impart motion to the housing and the attached medical device. The motion is configured to produce oscillatory motion of a frequency sufficient to concentrate shear stresses in a fluid boundary layer adjacent an inner wall of the medical device. The housing and the components supported in the housing are configured and arranged so that a device center of mass lies along or near the longitudinal axis of the channel.Type: GrantFiled: March 2, 2018Date of Patent: December 7, 2021Assignee: THE CLEVELAND CLINIC FOUNDATIONInventors: Jamshid Karimov, Kiyotaka Fukamachi, Ray Dessoffy
-
Patent number: 11185678Abstract: A blood pump (20) includes a stator assembly comprising a motor stator (52), a fluid inlet (24), and a fluid outlet (26). A rotor assembly includes a motor rotor (54) and an impeller (40) rotatable about an axis (44) to move fluid from the inlet (24) to the outlet (26). An outflow sheath (300) directs the flow along the outside of the pump (20).Type: GrantFiled: December 17, 2018Date of Patent: November 30, 2021Assignees: THE CLEVELAND CLINIC FOUNDATION, FOSTER-MILLER, INC.Inventors: William A. Smith, Markus Lorenz, David Dudzinski, Hsiang Ming Chen, Peter A. Chapman, Jr., Charles J. Prisco, Nicholas G. Vitale, Stephan Weber
-
Patent number: 11172932Abstract: A hemostatic vessel band is provided. The hemostatic vessel band has a membrane. A plurality of cells extend transversely from a membrane second surface. Each of the cells has a cell chamber that is defined by the membrane second surface and a plurality of cell walls. When the hemostatic vessel band is selectively fastened circumferentially about a vessel to at least partially cover the target site. The hemostatic vessel band applies radially inward pressure to at least a portion of the vessel and at least a portion of the target site. Each cell chamber that is positioned transversely adjacent to at least a portion of the target site forms one isolation zone of a plurality of isolation zones. Each isolation zone is at least partially isolated from each of the other isolation zones and from any vessel surface adjacent to the isolation zone.Type: GrantFiled: September 8, 2017Date of Patent: November 16, 2021Assignee: THE CLEVELAND CLINIC FOUNDATIONInventors: Jamshid Karimov, Kiyotaka Fukamachi
-
Patent number: 11173029Abstract: A method for treating regurgitation of blood flow through a diseased heart valve is provided. The diseased heart valve including an annulus, an anterior valve leaflet, a posterior valve leaflet and a subvalvular apparatus. The method includes providing an apparatus comprising a substantially annular support member, at least one infra-annular support member securely connected thereto, and at least one anchoring element associated with the at least one infra-annular support member. The method further includes attaching the substantially annular support member to the annulus of the diseased heart valve and attaching proximal and distal ends of a prosthetic chordae tendineae to the at least one anchoring element and a papillary muscle, respectively, so that the papillary muscle is caused to move medially.Type: GrantFiled: January 28, 2019Date of Patent: November 16, 2021Assignee: THE CLEVELAND CLINIC FOUNDATIONInventor: Jose L. Navia
-
Patent number: 11160798Abstract: A method of treating or preventing a neuroinflammatory and/or neurodegenerative disease in a subject by administering a pharmaceutically effective amount of a CB2 receptor agonist is described. The CB2 receptor agonist can be a compound according to formula I or a pharmaceutically acceptable salt thereof, with R1 and R2 as defined herein. Administration of the CB2 receptor agonist activates CB2 receptors in the microglia, and can restore syntaptic plasticity, cognition, and memory in subjects having elevated levels of amyloid-ßpeptide in the brain.Type: GrantFiled: November 22, 2019Date of Patent: November 2, 2021Assignee: THE CLEVELAND CLINIC FOUNDATIONInventors: Mohamed Naguib Attala, David L. Brown
-
Patent number: 11147986Abstract: The effects of acute toxicity from a radiation procedure can be reduced without altering the radiation dose by temporally feathering the radiation procedure. Using temporal feathering, the radiation procedure delivers a total amount of radiation that is weighted amounts of radiation per day. The weighted amounts of radiation can be delivered according to a sequence plan that ensures the total dose of radiation is administered in the time period. The sequence plan includes one day of a high fractional dose of radiation and four days of a low fractional dose of radiation.Type: GrantFiled: August 6, 2018Date of Patent: October 19, 2021Assignee: THE CLEVELAND CLINIC FOUNDATIONInventor: Jacob Scott
-
Patent number: 11136368Abstract: Blocking peptides that inhibit FAK or NANOG binding to Cx26, and a method of treating cancer by administering these blocking peptides to a subject in need thereof are described.Type: GrantFiled: August 23, 2017Date of Patent: October 5, 2021Assignee: THE CLEVELAND CLINIC FOUNDATIONInventors: Justin D. Lathia, Ofer Reizes
-
Patent number: 11097965Abstract: A multiple-bore solute cartridge carrier 10) for use in a sterile fluid delivery system. The carrier includes a rotary housing (12) adapted for connection to the sterile fluid delivery system. The rotary housing has one or more bores (30) configured to receive a solute cartridge. The rotary housing, when connected to the sterile fluid delivery system, is selectively rotatable to facilitate creation of a desired sterile solution when sterile water from the fluid delivery system is flowed through the solute cartridge.Type: GrantFiled: March 14, 2016Date of Patent: August 24, 2021Assignees: THE CLEVELAND CLINIC FOUNDATION, PARKER-HANNIFIN CORPORATIONInventors: Joseph Foss, Paul Resendes, Gino Banco, Andrew Sylvester
-
Patent number: 11090070Abstract: A method of restoring perfusion to a blood vessel with an obstruction. The method includes delivering an expandable member into the blood vessel, said expandable member having a tubular mesh defined between a proximal end and a distal end; causing the expandable member to expand and compress the obstruction; and dislodging the obstruction to restore blood flow through the blood vessel.Type: GrantFiled: January 30, 2019Date of Patent: August 17, 2021Assignee: THE CLEVELAND CLINIC FOUNDATIONInventors: David Fiorella, Henry Woo
-
Patent number: 11090284Abstract: Provided herein are methods, kits and compositions for the treatment and/or prevention of ovarian cancer through the induction of an immune response against Anti-Mullerian Hormone Receptor, Type II (AMHR2).Type: GrantFiled: September 2, 2016Date of Patent: August 17, 2021Assignee: The Cleveland Clinic FoundationInventors: Vincent K. Tuohy, Suparna Mazumder, Justin M. Johnson
-
Patent number: 11083560Abstract: Methods of treating airway stenosis are provided. Methods include gradually dilating the stenotic region of a patient's airway lumen with sequentially implanted customized airway stents. The airway stents are sequentially implanted until the diameter of the stenotic region of the patient's airway has substantially the same diameter as the diameter of an adjacent healthy region of the patient's airway lumen.Type: GrantFiled: January 14, 2020Date of Patent: August 10, 2021Assignees: THE CLEVELAND CLINIC FOUNDATION, NEW COS INCInventors: Thomas Gildea, Keith Grafmeyer
-
Patent number: 11076954Abstract: A gradually-expandable stent includes a base ring completely encircling a central valve-accepting area. A plurality of uprights is provided. Each upright includes two longitudinally extending upright struts. Each upright strut has a strut base directly connected to the base ring and a strut tip directly attached to the other strut tip of the upright strut at a rounded upright apex. The upright apex is longitudinally spaced from the base ring. At least one expansion feature is associated with the base ring and gradually expands to enlarge the central valve-accepting area toward a maximum valve-accepting area responsive to growth of the patient over an extended dwell time.Type: GrantFiled: September 20, 2018Date of Patent: August 3, 2021Assignee: THE CLEVELAND CLINIC FOUNDATIONInventors: Hani Najm, Kelly B. Emerton, Alex Lewis, Justin Metcalf